Literature DB >> 2427588

Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.

S S Graves, J Bramhall, B Bonavida.   

Abstract

Previous studies in our laboratory on the natural killer (NK) lytic mechanism demonstrated that following interaction of target cell with effector cell, the effector cell releases NK cytotoxic factors (NKCF) that can then bind to and lyse the target cell. This study investigates the mechanism by which the target cell signals the effector cell to release NKCF. Studies on other cell systems with secretory functions have indicated that receptor-induced transmembrane signaling leads to the metabolism of phosphatidylinositol and activation of protein kinase C (PKC) by increased cytosolic Ca++ and diacylglycerol (DAG). We tested the hypothesis that a similar sequence of activation events occurs in human NK cells by examining the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), and the calcium ionophores A23187 and ionomycin in their ability to induce release of NKCF. The amount of NKCF released was determined in a 20-hr 51Cr release assay against an NK-sensitive target cell. A23187, ionomycin, or TPA alone did not induce release of NKCF. However, ionophores (200 mM) in conjunction with TPA (20 ng/ml) induced release of NKCF. Several properties of the induced NKCF by TPA and ionophores were concordant with those of the NK cell-mediated cytotoxicity (CMC) reaction. The kinetics of release were faster (less than 1 hr) than when either Con A or target cells were used to stimulate NKCF. Only NK-sensitive target cells were killed by NKCF. Pretreatment of effector cells with interferon enhanced release of NKCF from effector cells. Several lines of evidence suggested that the pathway of activation takes place through phosphatidyl inositol metabolism. Activation of PKC was indicated because TPA and A23187 enhanced protein phosphorylation in the LGL-enriched fraction. Experiments that made use of oleoyl acetyl glycerol, a synthetic DAG, showed release of NKCF in the absence of A23187 but was augmented by the ionophore. The above studies suggest that NKCF is released from NK effector cells within a period of time consistent with NK CMC, and the release of NKCF results either directly or indirectly from protein phosphorylation by PKC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427588

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma.

Authors:  R H Brookes; M C Kew; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Role of protein kinase C in TBT-induced inhibition of lytic function and MAPK activation in human natural killer cells.

Authors:  Abraham B Abraha; Krupa Rana; Margaret M Whalen
Journal:  Arch Environ Contam Toxicol       Date:  2010-11       Impact factor: 2.804

3.  Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function.

Authors:  M M Whalen; A D Bankhurst
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

4.  Activation of protein kinase C and protein kinase D in human natural killer cells: effects of tributyltin, dibutyltin, and tetrabromobisphenol A.

Authors:  Krupa Rana; Margaret Whalen
Journal:  Toxicol Mech Methods       Date:  2015-07-31       Impact factor: 2.987

5.  Effects of pertussis toxin treatment on human natural killer cell function.

Authors:  M M Whalen; R N Doshi; A D Bankhurst
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

6.  Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells.

Authors:  N M Valiante; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.